Country |
Year |
N. of clients |
Mean age |
% |
% |
% Male |
% injecting main drug | |
|---|---|---|---|---|---|---|---|---|
Belgium |
(1) |
1999 |
4826 |
24.5 |
63.0 |
13.0 |
76.0 |
8.0 |
Czech Republic |
|
2004 |
4600 |
22.7 |
69.9 |
5.3 |
67.0 |
60.7 |
Denmark |
|
2004 |
1696 |
28.4 |
43.0 |
23.4 |
76.7 |
4.6 |
Germany |
|
2004 |
13204 |
24.2 |
64.0 |
10.0 |
82.0 |
10.0 |
Greece |
|
2004 |
2162 |
27.3 |
43.8 |
16.7 |
83.0 |
39.2 |
Spain |
(2) |
2002 |
17228 |
28.3 |
37.0 |
20.0 |
85.0 |
5.9 |
France |
(3) |
2003 |
7208 |
28.5 |
39.1 |
21.7 |
80.0 |
|
Ireland |
(4) |
2003 |
2178 |
23.7 |
62.7 |
8.6 |
77.0 |
17.3 |
Italy |
|
2004 |
34308 |
30.6 |
31.0 |
28.0 |
87.7 |
43.0 |
Cyprus |
|
2004 |
227 |
26.7 |
52.3 |
14.6 |
90.0 |
34.8 |
Latvia |
|
2004 |
438 |
21.7 |
75.1 |
8.9 |
76.0 |
44.9 |
Lithuania |
|
2004 |
425 |
26.2 |
67.7 |
6.0 |
84.7 |
|
Luxembourg |
(9) |
2003 |
24 |
27.3 |
|
|
|
|
Hungary |
|
2004 |
5655 |
26.7 |
56.0 |
16.0 |
72.0 |
5.6 |
Malta |
|
2004 |
167 |
23.3 |
67.7 |
6.0 |
80.2 |
|
Netherlands |
|
2004 |
4785 |
29.4 |
40.0 |
26.0 |
78.0 |
1.7 |
Austria |
(5) |
2004 |
847 |
26.3 |
52.8 |
15.6 |
75.0 |
100.0 |
Poland |
(6) |
2003 |
6697 |
26.0 |
64.5 |
15.3 |
76.0 |
|
Portugal |
|
2004 |
5023 |
31.0 |
19.5 |
28.6 |
84.0 |
|
Slovenia |
(7) |
2004 |
526 |
23.1 |
68.0 |
5.0 |
75.6 |
50.1 |
Slovakia |
|
2004 |
1045 |
23.0 |
69.3 |
7.6 |
82.6 |
31.6 |
Finland |
|
2004 |
735 |
23.5 |
70.2 |
8.3 |
69.8 |
34.2 |
Sweden |
|
2004 |
1413 |
31.1 |
40.4 |
35.0 |
65.0 |
16.8 |
United Kingdom |
(8) |
2004 |
29865 |
31.0 |
39.0 |
22.0 |
72.0 |
29.0 |
Bulgaria |
|
2004 |
667 |
22.2 |
76.5 |
1.5 |
84.0 |
61.8 |
Romania |
|
2004 |
710 |
27.9 |
56.0 |
17.0 |
78.0 |
55.0 |
Turkey |
|
2004 |
599 |
26.9 |
45.3 |
16.3 |
90.5 |
15.0 |
Notes: Data were not available for: Estonia, Norway, Turkey (1) Last data available refer to 1999. (2) Last data available refer to 2002. (3) Data on treatment demand referred to the annual census on clients in treatment carried out in November 2003. Last data available refer to 2003. (4) Last data available refer to 2003. (5) Data refer to clients in substitution treatment only; figures for opioids as main drug and injecting use are 100 %. (6) Last data available refer to 2003. (7) Data refer only to outpatient treatment centres. (8) Data relate to the period from 1 April 2003 to 31 March 2004 for UK. (9) Data on first treatment were not reported in 2004 as the figures were too small. See also 'General notes for interpreting data' on the Explanatory notes and help page. Sources: 2005 Reitox national reports - Standard Table 3 (see Table TDI-1 for details on sources) | ||||||||